Healthcare -
Biotechnology - NASDAQ - US
$ 0.96
-5.88 %
$ 200 M
Market Cap
-1.35
P/E
SGMO - OPERATING EXPENSES
Operating Expenses SGMO - Sangamo Therapeutics, Inc.
450 M
LAST VALUE
23.74%
2 YEAR CAGR
22.74%
5 YEAR CAGR
24.39%
10 YEAR CAGR